Optical Imaging (OI) for rheumatoid arthritis is a novel imaging modality. With the high number of people affected by this disease, especially in western countries, the availability of OI as an ...

A link between rheumatoid arthritis and appendicitis has been investigated before, but newer research has not confirmed these findings. Rheumatoid arthritis is an autoimmune disease where the ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Rheumatoid arthritis (RA) is an inflammatory, autoimmune condition that affects not only joints but also organs, including eyes. While it can have painful and debilitating effects if left untreated, ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

1 Amsterdam Rheumatology and Immunology Center, Amsterdam UMC - Location VUmc, Department of Rheumatology, Amsterdam, Netherlands 2 Amsterdam Public Health, Amsterdam UMC – location VUmc, Department ...

and rheumatoid arthritis (RA) are both destructive arthritides but may differ substantially in their periarticular bone changes. Objectives To investigate the differences in the structural changes of ...

The chronic pain of arthritis and the medications used to treat it can drain you. What can you do day to day to ease the fatigue?

Avtozma (tocilizumab-anoh, Celltrion) is approved for the treatment of multiple autoimmune diseases, including rheumatoid arthritis, giant cell arteritis, and both polyarticular and systemic forms ...

Trusted resource of information on Medical Oncology that includes articles, news, diet & nutrition, multimedia presentations, ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of menopausal hormone therapy, according to data published in Rheumatology.